Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02813083 · ClinicalTrials.gov registry record
Detection of Pathological Lymphocytes in Patients With Autoimmune Disease
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 129
- Enrollment target
NCT02813083: Completed study, sponsored by University of Minnesota.
NCT02813083 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02813083 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
This study will help the investigators design a method to detect the disease-causing immune cells in patients with rheumatoid arthritis (RA). Such methods are not currently available, but if successful, would help scientists to better understand the causes of RA.
Interventions
- OTHER No intervention (observational)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2011-08 |
| Est. Completion | 2023-09 |
What the finished NCT02813083 record still lists
NCT02813083 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention (observational) is the first listed.
NCT02813083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02813083 about?
NCT02813083 is a clinical study titled "Detection of Pathological Lymphocytes in Patients With Autoimmune Disease". This study will help the investigators design a method to detect the disease-causing immune cells in patients with rheumatoid arthritis (RA). Such methods are not currently available, but if successful, would help scientists to better understand the causes of RA.
What is the current status of trial NCT02813083?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2011-08. Estimated completion is 2023-09.
What interventions are being tested in trial NCT02813083?
The interventions under investigation include: No intervention (observational) (OTHER).
Who is sponsoring clinical trial NCT02813083?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia